ES2024077A6 - Procedimiento de preparacion de derivados de estireno substituido. - Google Patents

Procedimiento de preparacion de derivados de estireno substituido.

Info

Publication number
ES2024077A6
ES2024077A6 ES8900368A ES8900368A ES2024077A6 ES 2024077 A6 ES2024077 A6 ES 2024077A6 ES 8900368 A ES8900368 A ES 8900368A ES 8900368 A ES8900368 A ES 8900368A ES 2024077 A6 ES2024077 A6 ES 2024077A6
Authority
ES
Spain
Prior art keywords
stands
nitrogen atom
alkyl
general formula
new compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8900368A
Other languages
English (en)
Inventor
Zoltan Budai
Lujza Petocz
Tibor Mezei
Nee Kiszelly Eniko Szirt
Nee Hegedus Maria Szeczey
Gabor Gigler
Nee Esess Klara Reiter
Aranka Furdyga
Istvan Gyertyan
Istvan Gacsalyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of ES2024077A6 publication Critical patent/ES2024077A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/34—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C251/44—Oximes with oxygen atoms of oxyimino groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with the carbon atom of at least one of the oxyimino groups being part of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DE DERIVADOS DE ESTIRENO SUSTITUIDO, SIENDO LOS DERIVADOS DE LA FORMULA GENERAL I FORMULA Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES Y SALES DE AMONIO CUATERNARIO (DONDE A, RBS1, RBS2, RBS3 Y RBS4 TIENEN EL SIGNIFICADO DADO EN LA DESCRIPCION) QUE COMPRENDE LA REACCION DE UN DERIVADO DE ESTILBENO CON UN DERIVADO AMINOALQUILO. LOS COMPUESTOS PREPARADOS POR DICHO PROCEDIMIENTO POSEEN PROPIEDADES TERAPEUTICAS VALIOSAS Y EJERCEN UN EFECTO TRANQUILIZANTE-SEDANTE, ANTIDEPRESOR, ANTILEPTICO, ANTIPARKINSON, ANALGESICO, DE ANESTESIA LOCAL, INHIBICION DE SECRECION DE ACIDO GASTRICO Y/O ANTIAGINAL PARTICULARMENTE UTIL.
ES8900368A 1987-12-31 1988-12-30 Procedimiento de preparacion de derivados de estireno substituido. Expired - Lifetime ES2024077A6 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU876171A HU202195B (en) 1987-12-31 1987-12-31 Process for producing new substituted styrene derivatives and medical compositions comprising such compounds

Publications (1)

Publication Number Publication Date
ES2024077A6 true ES2024077A6 (es) 1992-02-16

Family

ID=10971303

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8900368A Expired - Lifetime ES2024077A6 (es) 1987-12-31 1988-12-30 Procedimiento de preparacion de derivados de estireno substituido.

Country Status (24)

Country Link
US (1) US4939142A (es)
JP (1) JPH0222258A (es)
CN (1) CN1022103C (es)
AT (1) AT396362B (es)
AU (1) AU610966B2 (es)
BE (1) BE1004906A3 (es)
CA (1) CA1326484C (es)
CH (1) CH678322A5 (es)
CS (1) CS274494B2 (es)
DD (1) DD287491A5 (es)
DE (1) DE3900028A1 (es)
DK (1) DK728888A (es)
ES (1) ES2024077A6 (es)
FI (1) FI90867C (es)
FR (1) FR2625501B1 (es)
GB (1) GB2213481B (es)
GR (1) GR1002384B (es)
HU (1) HU202195B (es)
IL (1) IL88827A (es)
IT (1) IT1227919B (es)
NL (1) NL8803221A (es)
PL (1) PL154358B1 (es)
SE (1) SE503227C2 (es)
YU (1) YU47605B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT67314A (en) * 1993-04-09 1995-03-28 Egyt Gyogyszervegyeszeti Gyar Process for prepg. new trisubstituted cykloalkane deriv.s and pharmaceutical compn.s contg. them
US5849761A (en) * 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
US6423714B2 (en) * 2000-03-13 2002-07-23 Ortho Mcneil-Pharmaceutical, Inc.. Cyclohexene derivatives useful as antagonists of the motilin receptor
US7415634B2 (en) * 2004-03-25 2008-08-19 International Business Machines Corporation Method for fast system recovery via degraded reboot
JP4912281B2 (ja) * 2007-11-27 2012-04-11 三菱電機株式会社 回路基板のはんだ付け用治具
US20100021276A1 (en) * 2008-07-24 2010-01-28 James Baughman Tilt loading platform for wheeled vehicles
AU2016250265A1 (en) * 2015-04-15 2017-10-12 Valent Biosciences Llc (S)-2'-vinyl-abscisic acid derivatives
WO2019084476A1 (en) * 2017-10-26 2019-05-02 University Of Tennessee Research Foundation ANTAGONISTS OF FIBROBLAST GROWTH FACTOR 23 AND RELATED COMPOSITIONS AND METHODS
CN110305054B (zh) * 2019-07-19 2021-03-02 哈尔滨工业大学 一种双取代苯乙烯类衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149043C (da) * 1976-01-27 1986-05-26 Egyt Gyogyszervegyeszeti Gyar Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
US4083978A (en) * 1976-01-27 1978-04-11 Egyt Gyogyszervegyeszeti Gyar Oxime ethers
HU180739B (en) * 1979-07-03 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing basic oxime-ethers
HU189227B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for preparing basic oxime-ethers
HU189226B (en) * 1983-02-08 1986-06-30 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing basic oxime-ethers
HU188250B (en) * 1983-02-08 1986-03-28 Egyt Gyogyszervegyeszeti Gyar,Hu Process for producing of basical oxim-ethers
HU197205B (en) * 1984-07-10 1989-03-28 Egyt Gyogyszervegyeszeti Gyar Process for production of medical compositions against angine
US4803286A (en) * 1987-08-19 1989-02-07 Merck & Co., Inc. Amino-2-hydroxypropyloximinoheterocycle α-blockers

Also Published As

Publication number Publication date
IL88827A0 (en) 1989-07-31
CH678322A5 (es) 1991-08-30
DK728888A (da) 1989-07-01
CA1326484C (en) 1994-01-25
AU2762788A (en) 1989-07-06
IL88827A (en) 1993-01-14
PL154358B1 (en) 1991-08-30
GB2213481B (en) 1991-07-17
YU47605B (sh) 1995-10-24
SE8804688D0 (sv) 1988-12-29
DK728888D0 (da) 1988-12-29
GR880100869A (el) 1994-03-31
FR2625501B1 (fr) 1993-05-21
FI90867C (fi) 1994-04-11
YU238288A (en) 1990-06-30
HUT48867A (en) 1989-07-28
GR1002384B (el) 1996-07-03
BE1004906A3 (fr) 1993-02-23
FI90867B (fi) 1993-12-31
IT1227919B (it) 1991-05-14
CS900788A2 (en) 1990-09-12
FI886066A (fi) 1989-07-01
NL8803221A (nl) 1989-07-17
AU610966B2 (en) 1991-05-30
HU202195B (en) 1991-02-28
SE503227C2 (sv) 1996-04-22
CN1034709A (zh) 1989-08-16
US4939142A (en) 1990-07-03
ATA320788A (de) 1992-12-15
FR2625501A1 (fr) 1989-07-07
PL276892A1 (en) 1989-08-21
SE8804688L (sv) 1989-07-01
AT396362B (de) 1993-08-25
GB8830417D0 (en) 1989-03-01
DD287491A5 (de) 1991-02-28
CN1022103C (zh) 1993-09-15
GB2213481A (en) 1989-08-16
CS274494B2 (en) 1991-04-11
JPH0222258A (ja) 1990-01-25
IT8823180A0 (it) 1988-12-30
DE3900028A1 (de) 1989-07-13

Similar Documents

Publication Publication Date Title
FI954105A0 (fi) Uusia 4-aminopyridiinejä, niiden valmistusmenetelmä sekä näitä yhdisteitä sisältäviä lääkkeitä
ES8607966A1 (es) Un procedimiento para preparar un derivado de dihidropiridina.
MX9504349A (es) Derivados de aroilpiperidina.
ES8302002A1 (es) Un procedimiento para la preparacion de nuevos derivados de cefalosporina.
IE782493L (en) Phosphonoformic acid derivatives
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
DE3777852D1 (de) Dekahydrochinolinderivate, verfahren zu ihrer herstellung, zwischenprodukte zu ihrer herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
ES2024077A6 (es) Procedimiento de preparacion de derivados de estireno substituido.
TNSN07357A1 (en) Indanyl-piperazine derivatives, method for preparing same and pharmaceutical compositions containing same
ES534505A0 (es) Un procedimiento para la preparacion de compuestos de 1, 4-dihidropiridina
ES486824A1 (es) Procedimiento para la preparacion de nuevos derivados de 4- (naftilmetil) piperidinas
ES8207180A1 (es) Procedimiento de fabricacion de derivados de tetrahidro-5,67,7a 4h-tieno (3,2-c) piridinona-2 .
EA200001101A1 (ru) НОВЫЕ ДИГИДРОФУРО[3,4-b]ХИНОЛИН-1-ОНЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ И СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
ES8404311A1 (es) Un procedimiento para la preparacion de derivados de etanolamina.
EP0335979A4 (en) Thienopyrimidine derivatives
AU655869B2 (en) An amphoteric tricyclic compound
DE60202970D1 (de) Substituierte alkylaminopyridazinonderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
PT90302A (pt) Processo para a preparacao de derivados de lactamas hetero-tetraciclicas
ES8101646A1 (es) Un procedimiento para producir un compuesto opticamente ac- tivo
AU4947996A (en) Arginine analogs acting as inhibitors of the NO synthase
EP0322251A3 (en) Benzothiopyran derivatives
FR2626470B1 (fr) Depresseur de l'inhibiteur de l'(alpha)2-plasmine
DE3367209D1 (en) Aminoethoxybenzylalcohol derivatives, process for their preparation and pharmaceutical compositions containing them
ES464773A1 (es) Procedimiento para la preparacion de 2,9-dioxatriciclo (4,3,1,03,7)decanos.
AU547599B2 (en) Tricyclic compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201